Tag Archive for: Healthcare
Sector updates in August
Investment firms venBio has raised $528M to invest in biotech companies across all stages working on diseases with unmet needs TPG has raised $580m for its Life Science Innovations fund to assist emerging life science companies in advancing breakthrough technologies to clinical proof-of-concept Terumo Ventures has launched with $75m dedicated to medtech startups working in […]
Death cap poison: the latest weapon in the fight against cancer
The death cap mushroom is feared throughout much of the world because of the deadly toxin it contains, amanitin. But could the poison reputedly used by Agrippina to murder her husband, the Roman emperor Claudius, be used to destroy cancer, asks Richard Staines. Known to modern science as an inhibitor of RNA polymerase II, alpha-Amanitin […]
From $1bn deals to Smart RNA – read our news roundup
AstraZeneca buys Novo Holdings portfolio company Amolyt in potential $1bn+ deal Novo Holdings A/S and Sofinnova Partners, two leading life sciences investors, made headlines on Thursday when portfolio company Amolyt Pharma entered into a definitive agreement to be acquired by AstraZeneca at a purchase price of US$800 million upfront and a potential milestone payment of […]
JPM ’24: The year’s healthcare barometer gives a more sunny outlook
The JPM Healthcare Conference of 2024 may not have witnessed a mega-merger announcement, but there is anticipation that the M&A market could pick up this year, with predictions that the economic headwinds of recent years could turn into tailwinds. The recent M&A Firepower report from EY, formerly known as Ernst & Young, has forecast a […]
